Target intelligence / Profile preview

Paracrine signaling pathways involved in cardiac repair and regeneration

Molecular classification
Other
01

Overview

Paracrine signaling pathways involved in cardiac repair and regeneration refer to the complex network of secreted factors—including growth factors (e.g., VEGF, IGF-1, HGF, FGF), cytokines (e.g., IL-6, TNF-α), microRNAs, and extracellular vesicles (EVs, exosomes)—released by various cardiac and stromal cells (including mesenchymal and cardiac progenitor or stem cells) following myocardial injury[1][3][5]. These molecules do not act at the site of release, but rather affect neighboring or distant target cells, orchestrating survival, proliferation, angiogenesis, inflammation modulation, and tissue remodeling necessary for cardiac repair and regeneration[3][6]. While several critical signaling pathways (Wnt, PI3K/Akt, Notch, TGF-β, Hippo, VEGF) have been identified as central to these processes[2][4][7], the broad "paracrine signaling pathways" concept is not a druggable target itself but informs strategy for the identification and exploitation of specific factors or mediators for therapeutic purposes.

Other names
Paracrine mechanisms of cardiac repairParacrine factors in heart regenerationParacrine cell communication in the heart
02

Mechanism of action

Stimulation of endogenous repair via growth factor signaling (e.g., VEGF, IGF-1, FGF); Enhancement of cell survival and proliferation via paracrine trophic support; Inflammation modulation through cytokine secretion (e.g., IL-6, TNF-α); Angiogenesis promotion by vascular growth factors; Anti-apoptotic signaling in cardiomyocytes

03

Biological functions

Signal transductionCell proliferationCell survivalAngiogenesis (formation of new blood vessels)Immune responseTissue remodelingCell differentiationAnti-apoptosis
04

Disease associations

Cardiovascular diseaseMyocardial infarctionHeart failureIschemic heart diseases
05

Safety considerations

Off-target effects due to pleiotropic nature of paracrine factorsRisk of uncontrolled cell proliferation, fibrosis, or tumorigenesis with some growth factor/cytokine treatmentsImmune or allergic responses to biologics or cell-derived productsChallenges in regulating spatial and temporal activity of secreted factors
06

Interacting drugs

Growth factor mimetics (IGF-1, VEGF analogs)

2 more in the full profile.

07

Biomarkers

Circulating extracellular vesiclesLevels of paracrine factors (VEGF, IGF-1, HGF, FGF)Inflammatory cytokines (IL-6, TNF-α)Markers of cardiomyocyte proliferation

Beyond the preview

Go deeper on Paracrine signaling pathways involved in cardiac repair and regeneration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine signaling pathways involved in cardiac repair and regeneration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call